Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Autoimmune Dementia: Predictors of Neuronal Synaptic Antibodies in Patients With New-ONset Cognitive Impairment and Their Relevance in Non-encephalitic formS: The ADONIS Study

NCT06321588 is registered in ClinicalTrials.gov with Azienda Usl di Bologna as lead sponsor.

NCT NCT06321588
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06321588 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Autoimmune Dementia: Predictors of Neuronal Synaptic Antibodies in Patients With New-ONset Cognitive Impairment and Their Relevance in Non-encephalitic formS: The ADONIS Study
Lead sponsor
Azienda Usl di Bologna
Phase
Observational
Overall status
Recruiting
Start date
May 10, 2023
Completion date
June 30, 2026
Enrollment
300 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive impairment, dementia